CD8A and neoplasm: We further showed that the combination of TMB and CNA burden better stratifies patients into subsets with differential response to ICB with unique CNA profiles, enriched pathways, and predicted transcriptional and phenotypic effects related to immune signaling and CD8+ T-cell abundance in the tumor microenvironment.